NO964121D0 - Pyrimidin- eller triazin-karboksylsyrederivater for anvendelse som legemidler - Google Patents

Pyrimidin- eller triazin-karboksylsyrederivater for anvendelse som legemidler

Info

Publication number: NO964121D0
Authority: NO; Norway
Prior art keywords: pyrimidine; drugs; carboxylic acid; acid derivatives; pct
Prior art date: 1994-03-31

Application number

NO964121A

Other languages

English (en)

Other versions

NO310497B1 (no

NO964121L (no

Inventor

Ernst Baumann

Uwe Josef Vogelbacher

Joachim Rheinheimer

Dagmar Klinge

Hartmut Riechers

Burkhard Kroger

Siegfried Bialojan

Claus Bollschweiler

Wolfgang Wernet

Liliane Unger

Manfred Raschack

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-03-31

Filing date

1996-09-27

Publication date

1996-09-27

1996-09-27 Application filed by Basf Ag filed Critical Basf Ag

1996-09-27 Publication of NO964121D0 publication Critical patent/NO964121D0/no

1996-11-26 Publication of NO964121L publication Critical patent/NO964121L/no

2001-07-16 Publication of NO310497B1 publication Critical patent/NO310497B1/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

NO19964121A 1994-03-31 1996-09-27 Pyrimidin- eller triazin-karboksylsyrederivater, hvilke kan anvendes som legemidler NO310497B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4411225A DE4411225A1 (de)	1994-03-31	1994-03-31	Verwendung von Carbonsäurederivaten als Arzneimittel
PCT/EP1995/001099 WO1995026716A1 (de)	1994-03-31	1995-03-23	Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel

Publications (3)

Publication Number	Publication Date
NO964121D0 true NO964121D0 (no)	1996-09-27
NO964121L NO964121L (no)	1996-11-26
NO310497B1 NO310497B1 (no)	2001-07-16

Family

ID=6514334

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19964121A NO310497B1 (no)	1994-03-31	1996-09-27	Pyrimidin- eller triazin-karboksylsyrederivater, hvilke kan anvendes som legemidler

Country Status (28)

Country	Link
US (1)	US5840722A (no)
EP (1)	EP0752854B1 (no)
JP (2)	JP4001622B2 (no)
KR (1)	KR100365629B1 (no)
CN (1)	CN1070701C (no)
AT (1)	ATE204471T1 (no)
AU (1)	AU695193B2 (no)
BR (1)	BR9507231A (no)
CA (1)	CA2186784C (no)
CZ (1)	CZ290684B6 (no)
DE (2)	DE4411225A1 (no)
DK (1)	DK0752854T3 (no)
ES (1)	ES2162916T3 (no)
FI (1)	FI118589B (no)
GR (1)	GR3036606T3 (no)
HR (1)	HRP950115B1 (no)
HU (1)	HU228063B1 (no)
IL (1)	IL113137A (no)
NO (1)	NO310497B1 (no)
NZ (1)	NZ283333A (no)
PL (1)	PL179580B1 (no)
PT (1)	PT752854E (no)
RU (1)	RU2163808C2 (no)
SI (1)	SI9520048A (no)
TW (1)	TW382594B (no)
UA (1)	UA44734C2 (no)
WO (1)	WO1995026716A1 (no)
ZA (1)	ZA952614B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4411225A1 (de) *	1994-03-31	1995-10-05	Basf Ag	Verwendung von Carbonsäurederivaten als Arzneimittel
DE19533023B4 (de)	1994-10-14	2007-05-16	Basf Ag	Neue Carbonsäurederivate, ihre Herstellung und Verwendung
DE19536891A1 (de) *	1995-10-04	1997-04-10	Basf Ag	Neue Aminosäurederivate, ihre Herstellung und Verwendung
DE19614533A1 (de)	1996-04-12	1997-10-16	Basf Ag	Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung
DE19636046A1 (de)	1996-09-05	1998-03-12	Basf Ag	Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten
US6030975A (en) *	1997-03-14	2000-02-29	Basf Aktiengesellschaft	Carboxylic acid derivatives, their preparation and use in treating cancer
DE19726146A1 (de) *	1997-06-19	1998-12-24	Basf Ag	Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
BR9811631A (pt) *	1997-09-04	2000-09-26	Basf Ag	Derivado de ácido carboxìlico e uso do mesmo
TR200001182T2 (tr)	1997-10-31	2000-11-21	Basf Aktiengesellschaft	Yeni karbonik asit türevleri, üretimleri ve kullanımları.
DE19806438A1 (de) *	1998-02-17	1999-08-19	Basf Ag	Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung
DE19809144A1 (de) *	1998-03-04	1999-09-09	Basf Ag	Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten
DE19809635A1 (de)	1998-03-06	1999-09-09	Basf Ag	Verfahren zur Darstellung von Endothelinrezeptorantagonisten vom Sulfanyltyp
US7566452B1 (en)	1999-05-04	2009-07-28	New York University	Cancer treatment with endothelin receptor antagonists
WO2002064573A1 (de) *	2001-02-14	2002-08-22	Abbott Gmbh & Co. Kg	Neue carbonsäurederivate mit alkylsubstituierten triazinen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten
US20040204422A1 (en) *	2003-04-14	2004-10-14	Abbott Gmbh & Co. Kg.	N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
EP2118073A2 (en) *	2007-02-02	2009-11-18	Concert Pharmaceuticals Inc.	Selective endothelin type-a antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69226813T2 (de) *	1991-06-07	1999-02-18	Ube Industries	Pyrimidin- oder Triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Herbizide
DE4313412A1 (de) *	1993-04-23	1994-10-27	Basf Ag	3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
DE4411225A1 (de) *	1994-03-31	1995-10-05	Basf Ag	Verwendung von Carbonsäurederivaten als Arzneimittel

1994
- 1994-03-31 DE DE4411225A patent/DE4411225A1/de not_active Withdrawn
1995
- 1995-03-09 HR HR950115A patent/HRP950115B1/xx not_active IP Right Cessation
- 1995-03-23 CA CA002186784A patent/CA2186784C/en not_active Expired - Lifetime
- 1995-03-23 SI SI9520048A patent/SI9520048A/sl unknown
- 1995-03-23 PT PT95914301T patent/PT752854E/pt unknown
- 1995-03-23 EP EP95914301A patent/EP0752854B1/de not_active Expired - Lifetime
- 1995-03-23 PL PL95316563A patent/PL179580B1/pl unknown
- 1995-03-23 DE DE59509537T patent/DE59509537D1/de not_active Expired - Lifetime
- 1995-03-23 AU AU21356/95A patent/AU695193B2/en not_active Expired
- 1995-03-23 KR KR1019960705420A patent/KR100365629B1/ko not_active IP Right Cessation
- 1995-03-23 DK DK95914301T patent/DK0752854T3/da active
- 1995-03-23 JP JP52539195A patent/JP4001622B2/ja not_active Expired - Lifetime
- 1995-03-23 US US08/718,377 patent/US5840722A/en not_active Expired - Lifetime
- 1995-03-23 RU RU96121628/14A patent/RU2163808C2/ru active
- 1995-03-23 BR BR9507231A patent/BR9507231A/pt not_active Application Discontinuation
- 1995-03-23 ES ES95914301T patent/ES2162916T3/es not_active Expired - Lifetime
- 1995-03-23 CZ CZ19962873A patent/CZ290684B6/cs not_active IP Right Cessation
- 1995-03-23 WO PCT/EP1995/001099 patent/WO1995026716A1/de active IP Right Grant
- 1995-03-23 NZ NZ283333A patent/NZ283333A/en not_active IP Right Cessation
- 1995-03-23 UA UA96104109A patent/UA44734C2/uk unknown
- 1995-03-23 AT AT95914301T patent/ATE204471T1/de active
- 1995-03-23 HU HU9602695A patent/HU228063B1/hu unknown
- 1995-03-23 CN CN95193167A patent/CN1070701C/zh not_active Expired - Lifetime
- 1995-03-27 IL IL11313795A patent/IL113137A/xx not_active IP Right Cessation
- 1995-03-28 TW TW084103012A patent/TW382594B/zh not_active IP Right Cessation
- 1995-03-30 ZA ZA952614A patent/ZA952614B/xx unknown
1996
- 1996-09-27 FI FI963885A patent/FI118589B/fi not_active IP Right Cessation
- 1996-09-27 NO NO19964121A patent/NO310497B1/no not_active IP Right Cessation
2001
- 2001-09-12 GR GR20010401467T patent/GR3036606T3/el unknown
2007
- 2007-02-15 JP JP2007034659A patent/JP4769742B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH09510984A (ja)	1997-11-04
FI118589B (fi)	2008-01-15
CZ287396A3 (en)	1997-04-16
DE4411225A1 (de)	1995-10-05
BR9507231A (pt)	1997-09-16
IL113137A (en)	1999-10-28
FI963885A (fi)	1996-11-26
CA2186784A1 (en)	1995-10-12
HRP950115A2 (en)	1997-10-31
NO310497B1 (no)	2001-07-16
UA44734C2 (uk)	2002-03-15
PT752854E (pt)	2002-02-28
CN1148807A (zh)	1997-04-30
HRP950115B1 (en)	2001-12-31
FI963885A0 (fi)	1996-09-27
KR970702042A (ko)	1997-05-13
DK0752854T3 (da)	2001-10-08
KR100365629B1 (ko)	2003-04-10
MX9604448A (es)	1997-07-31
HU9602695D0 (en)	1996-11-28
ATE204471T1 (de)	2001-09-15
SI9520048A (en)	1997-02-28
ES2162916T3 (es)	2002-01-16
IL113137A0 (en)	1995-06-29
JP4001622B2 (ja)	2007-10-31
NO964121L (no)	1996-11-26
CZ290684B6 (cs)	2002-09-11
ZA952614B (en)	1996-09-30
AU2135695A (en)	1995-10-23
DE59509537D1 (de)	2001-09-27
HU228063B1 (en)	2012-09-28
WO1995026716A1 (de)	1995-10-12
NZ283333A (en)	1997-02-24
JP4769742B2 (ja)	2011-09-07
EP0752854B1 (de)	2001-08-22
EP0752854A1 (de)	1997-01-15
GR3036606T3 (en)	2001-12-31
AU695193B2 (en)	1998-08-06
US5840722A (en)	1998-11-24
HUT75305A (en)	1997-05-28
RU2163808C2 (ru)	2001-03-10
PL316563A1 (en)	1997-01-20
PL179580B1 (pl)	2000-09-29
CN1070701C (zh)	2001-09-12
CA2186784C (en)	2007-02-20
TW382594B (en)	2000-02-21
JP2007131645A (ja)	2007-05-31

Legal Events

Date	Code	Title	Description
2014-06-02	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE
2015-03-30	MK1K	Patent expired

Publication	Publication Date	Title
NO964121D0 (no)	1996-09-27	Pyrimidin- eller triazin-karboksylsyrederivater for anvendelse som legemidler
ES2102195T3 (es)	1997-07-16	Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides.
TR199800585T2 (xx)	1998-07-21	COX-2 �nhibit�rleri Olarak (Metils�lfonil)Fenil-2-(5H)-Furanonlar.
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
ES2173172T3 (es)	2002-10-16	Derivados de 1,3-dihidroindol-2-ona sustituidos en 3 por un grupo nitrogenado como agonistas y/o antagonistas de la vasopresina y/o de la octocina.
MX9301112A (es)	1994-07-29	Derivados de indol.
DK0678089T3 (da)	1996-11-18	N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
BR9610175A (pt)	1998-08-11	Composto processo de preparação do composto composição farmacêutica e utilização do composto
BR9306870A (pt)	1998-12-08	Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
BR9611572A (pt)	1999-03-30	Produção de um sal de ácido clavulânico
DK0678088T3 (da)	1996-11-18	N-acylpyrrolidiner og lægemidler til behandling og forebyggelse af cholecystokinin- og gastrinrelaterede sygdomme
ES2127937T3 (es)	1999-05-01	Procedimiento para la preparacion de derivados de indolizina.
ES2099973T3 (es)	1997-06-01	Derivados de ureido-acetamida su preparacion y los medicamentos que los contienen.
ES2116528T3 (es)	1998-07-16	Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.